Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : sciclone pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Skywatcher who wrote (1092)	5/12/2003 9:45:10 AM
From: JEB	Read Replies (2) \| Respond to of 1137

SciClone Added to NASDAQ Biotech Index MONDAY, MAY 12, 2003 6:30 AM - BusinessWire SAN MATEO, Calif., May 12, 2003 (BUSINESS WIRE) -- SciClone Pharmaceuticals, Inc. (SCLN) today announced that it has been selected to be added to the NASDAQ Biotechnology Index (NBI) effective Monday, May 19, 2003. All securities in the Index are listed on the NASDAQ National Market and meet minimum requirements including market value, average daily share volume and seasoning as a public company. Launched in 1993, the NASDAQ Biotech Index includes companies primarily engaged in using biomedical research for the discovery or development of novel treatments or cures for human diseases. The Index is ranked on a semi-annual basis in May and November and serves as the basis for the iShares NASDAQ Biotechnology Index Fund(SM) (IBB). For more information about the NASDAQ Biotechnology Index, including eligibility criteria, visit www.nasdaq.com. bigcharts.marketwatch.com{9E98FC96-F8A0-4E1F-99B7-9B67DBC6F496}&newsid=804381698&symb=SCLN&sid=8610